v3.26.1
Note 14 - Segment Reporting and Geographic Information - Segment Expenses (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Clinical and pre-clinical expenses $ 532 $ 115
Patent expenses 139 166
Personnel costs 666 1,088
Professional services 639 956
Other operational expenses 256 285
Other segment items 119 (26)
Segment net loss 2,351 2,584
Net loss (income) from discontinued operations 4,323 (3,754)
Consolidated net loss (income) $ 6,674 $ (1,170)